Multiple Sclerosis Center of Northeastern New York Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04550455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Keith Edwards, M.D. | MS Center of Northeastern New York, P.C. | Multiple Sclerosis Center of Northeastern New York